| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |